• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用常规磁共振成像评估进行性核上性麻痹患者的中脑萎缩情况。

Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging.

作者信息

Cosottini M, Ceravolo R, Faggioni L, Lazzarotti G, Michelassi M C, Bonuccelli U, Murri L, Bartolozzi C

机构信息

Department of Neuroscience, University of Pisa, Pisa, Italy.

出版信息

Acta Neurol Scand. 2007 Jul;116(1):37-42. doi: 10.1111/j.1600-0404.2006.00767.x.

DOI:10.1111/j.1600-0404.2006.00767.x
PMID:17587253
Abstract

OBJECTIVES

To assess midbrain atrophy through morphometric (linear, surface and volumetric) measurements in patients with clinically diagnosed progressive supranuclear palsy (PSP) and to establish the most accurate measure to be implemented in routine magnetic resonance (MR) protocol in distinguishing PSP from healthy subjects and MSA-p (multiple system atrophy, parkinsonian form) patients.

MATERIALS AND METHODS

We studied 15 patients with the diagnosis of probable PSP, seven patients with the diagnosis of probable MSA-p and 14 age-matched healthy volunteers. MR protocol includes a sagittal SE T1-weighted sequence for cross-sectional area and linear brainstem measurements and a 3D-FSPGR sequence for brainstem volume measurements.

RESULTS

A highly significant difference in the antero-posterior midbrain diameter, area and volume in PSP compared with control subjects was found. Only a measurement of the midbrain area and pons area enabled one to distinguish between PSP and MSA-p. Receiver operating characteristic analysis revealed that the midbrain area has the highest diagnostic accuracy in distinguishing between PSP and other conditions, with a sensitivity of 100% and specificity of 90.5%. The addition of the midbrain area/pons area ratio (A(ms)/A(pn) ratio) measurement improves the specificity in distinguishing between PSP and MSA.

CONCLUSIONS

Morphological indexes indicate midbrain atrophy in PSP patients The combination of the A(ms) and A(ms)/A(pn) ratio measurements allows to discriminate between PSP and other conditions.

摘要

目的

通过对临床诊断为进行性核上性麻痹(PSP)患者进行形态学测量(线性、表面积和体积)来评估中脑萎缩情况,并确定在常规磁共振(MR)检查方案中用于区分PSP与健康受试者及多系统萎缩帕金森型(MSA-p)患者的最准确测量方法。

材料与方法

我们研究了15例确诊为可能PSP的患者、7例确诊为可能MSA-p的患者以及14名年龄匹配的健康志愿者。MR检查方案包括用于测量脑干横截面积和线性尺寸的矢状面SE T1加权序列,以及用于测量脑干体积的三维快速扰相梯度回波(3D-FSPGR)序列。

结果

与对照组相比,PSP患者的中脑前后径、面积和体积存在高度显著差异。只有中脑面积和脑桥面积的测量能够区分PSP和MSA-p。受试者操作特征分析显示,中脑面积在区分PSP与其他疾病方面具有最高的诊断准确性,敏感性为100%,特异性为90.5%。增加中脑面积/脑桥面积比值(A(ms)/A(pn)比值)测量可提高区分PSP和MSA的特异性。

结论

形态学指标表明PSP患者存在中脑萎缩。A(ms)和A(ms)/A(pn)比值测量相结合能够区分PSP与其他疾病。

相似文献

1
Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging.采用常规磁共振成像评估进行性核上性麻痹患者的中脑萎缩情况。
Acta Neurol Scand. 2007 Jul;116(1):37-42. doi: 10.1111/j.1600-0404.2006.00767.x.
2
New and reliable MRI diagnosis for progressive supranuclear palsy.进行性核上性麻痹的新型可靠MRI诊断
Neurology. 2005 Jun 28;64(12):2050-5. doi: 10.1212/01.WNL.0000165960.04422.D0.
3
[A follow-up study on brainstem atrophy in progressive supranuclear palsy--when does brain MRI contribute to the differential diagnosis between progressive supranuclear palsy and Parkinson disease?].[进行性核上性麻痹脑干萎缩的随访研究——脑部磁共振成像何时有助于进行性核上性麻痹与帕金森病的鉴别诊断?]
Rinsho Shinkeigaku. 2003 Jul;43(7):392-7.
4
Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.扩散加权磁共振成像可区分多系统萎缩帕金森综合征型与进行性核上性麻痹。
Mov Disord. 2007 Jan;22(1):68-74. doi: 10.1002/mds.21204.
5
Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy.磁共振帕金森病指数和中脑-脑桥面积比诊断准确率,以区分进行性核上性麻痹与帕金森病和多系统萎缩的帕金森变异型。
Mov Disord. 2010 Oct 30;25(14):2444-9. doi: 10.1002/mds.23351.
6
Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy.基于磁共振成像的容积测定法可区分特发性帕金森综合征与多系统萎缩及进行性核上性麻痹。
Ann Neurol. 1999 Jan;45(1):65-74.
7
MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.用于区分进行性核上性麻痹与帕金森病及多系统萎缩帕金森变异型的磁共振成像指标。
Radiology. 2008 Jan;246(1):214-21. doi: 10.1148/radiol.2453061703. Epub 2007 Nov 8.
8
Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.基于磁共振成像的容积测量法可区分进行性核上性麻痹与皮质基底节变性。
Neuroimage. 2004 Feb;21(2):714-24. doi: 10.1016/j.neuroimage.2003.09.070.
9
A combination of CSF tau ratio and midsaggital midbrain-to-pons atrophy for the early diagnosis of progressive supranuclear palsy.联合脑脊液 tau 比值与中脑桥脑矢状位萎缩对进行性核上性麻痹的早期诊断。
J Alzheimers Dis. 2010;22(1):195-203. doi: 10.3233/JAD-2010-100333.
10
MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease.MRI 测量 Richardson 综合征、进行性核上性麻痹-帕金森病和帕金森病患者的脑干结构。
Mov Disord. 2011 Feb 1;26(2):247-55. doi: 10.1002/mds.23293. Epub 2010 Dec 15.

引用本文的文献

1
In search of the optimal MRI marker for progressive supranuclear palsy: a large, single-center, retrospective study on the effect of phenotype, diagnostic certainty and disease duration.寻找进行性核上性麻痹的最佳MRI标志物:一项关于表型、诊断确定性和疾病持续时间影响的大型单中心回顾性研究。
J Neurol. 2025 Jul 21;272(8):523. doi: 10.1007/s00415-025-13262-2.
2
Brainstem and cerebellar radiological findings in progressive supranuclear palsy.进行性核上性麻痹的脑干和小脑影像学表现
Brain Commun. 2025 Feb 5;7(1):fcaf051. doi: 10.1093/braincomms/fcaf051. eCollection 2025.
3
Simple biomarkers to distinguish Parkinson's disease from its mimics in clinical practice: a comprehensive review and future directions.
在临床实践中区分帕金森病与其模仿疾病的简单生物标志物:全面综述与未来方向
Front Neurol. 2024 Sep 19;15:1460576. doi: 10.3389/fneur.2024.1460576. eCollection 2024.
4
Clinical and neuroimaging characteristics of primary lateral sclerosis with overlapping features of progressive supranuclear palsy.原发性侧索硬化症伴进行性核上性麻痹重叠特征的临床和神经影像学特征。
Eur J Neurol. 2024 Aug;31(8):e16320. doi: 10.1111/ene.16320. Epub 2024 Apr 30.
5
Planimetric and Volumetric Brainstem MRI Markers in Progressive Supranuclear Palsy, Multiple System Atrophy, and Corticobasal Syndrome. A Systematic Review and Meta-Analysis.进行性核上性麻痹、多系统萎缩和皮质基底节综合征的脑干平面测量和容积MRI标记物:一项系统评价和荟萃分析
Neurol Int. 2023 Dec 19;16(1):1-19. doi: 10.3390/neurolint16010001.
6
The Role of Clinical Assessment in the Era of Biomarkers.临床评估在生物标志物时代的作用。
Neurotherapeutics. 2023 Jul;20(4):1001-1018. doi: 10.1007/s13311-023-01410-3. Epub 2023 Aug 18.
7
Midbrain and pons MRI shape analysis and its clinical and CSF correlates in degenerative parkinsonisms: a pilot study.中脑和脑桥 MRI 形态分析及其在变性帕金森病中的临床和 CSF 相关性:一项初步研究。
Eur Radiol. 2023 Jul;33(7):4540-4551. doi: 10.1007/s00330-023-09435-0. Epub 2023 Feb 11.
8
Superior cerebellar peduncle atrophy of progressive supranuclear palsy on phase difference enhanced imaging: a comparison with Parkinson's disease.相位差增强成像上的进行性核上性麻痹的小脑上脚萎缩:与帕金森病的比较。
Neuroradiology. 2023 Apr;65(4):719-727. doi: 10.1007/s00234-023-03119-8. Epub 2023 Jan 20.
9
Progressive supranuclear palsy and corticobasal degeneration: novel clinical concepts and advances in biomarkers.进行性核上性麻痹和皮质基底节变性:新的临床概念和生物标志物的进展。
Arq Neuropsiquiatr. 2022 May;80(5 Suppl 1):126-136. doi: 10.1590/0004-282X-ANP-2022-S134.
10
Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms.形态计量成像和定量磁化率映射在帕金森病诊断中的互补作用
Eur J Neurol. 2022 Oct;29(10):2944-2955. doi: 10.1111/ene.15447. Epub 2022 Jun 27.